Should Preoperative or Postoperative Therapy Be Administered in the Management of Rectal Cancer?

Seminars in Oncology

Volumn 33, Issue SUPPL. 11, 2006, Pages 64-69

  Kachnic, Lisa A ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLIC ACID; IRINOTECAN; OXALIPLATIN;

ADJUVANT THERAPY; ARTICLE; CANCER PATIENT; CLINICAL TRIAL; CONTINUOUS INFUSION; DIARRHEA; HUMAN; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM CANCER; SPHINCTER; ULTRASOUND;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; POSTOPERATIVE CARE; PREOPERATIVE CARE; RECTAL NEOPLASMS;

EID: 33845404680     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2006.10.018     Document Type: Article

References (45)

1. Rich T., Gunderson L.L., Lew R., et al. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 52 (1983) 1317-1329
2. Mendenhall W.M., Million R.R., and Pfaff W.W. Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: Indications in treatment planning with adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 9 (1983) 977-985
3. Piliphen S.J., Heilweil M., Quan S.H., et al. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 53 (1984) 1354-1362
4. Gastrointestinal Tumor Study Group. Prolongation of the disease-free survival in surgically treated rectal carcinoma. N Engl J Med 312 (1985) 1465-1472
5. Krook J.E., Moertel C.G., Gunderson L.L., et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324 (1991) 709-715
6. National Institutes of Health Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264 (1990) 1444-1450
7. Fisher B., Wolmark N., Rockette H., et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP Protocol R-01. J Natl Cancer Inst 80 (1988) 21-29
8. Wolmark N., Wieand S., Hyams D.M., et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiation for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 92 (2000) 388-396
9. O'Connell M.J., Martenson J.A., Wieand H.S., et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion 5-FU with radiation therapy after curative surgery. N Engl J Med 331 (1994) 502-507
10. Tepper J.E., O'Connell M.J., Niedzwiecki D.R., et al. Adjuvant therapy in rectal cancer: Analysis of stage, sex, and local control - Final report of Intergroup 0114. J Clin Oncol 20 (2002) 1744-1750
11. Smalley S.R., Benedetti J., Williamson S., et al. Phase III trial of fluorouracil- based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer. J Clin Oncol 24 (2006) 3542-3547 GI INT 0144
12. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336 (1997) 980-987
13. Dahlberg M., Glimelius B., Graf W., et al. Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum 41 (1998) 543-549
14. King M., Tolan S., Giridharan S., et al. Late toxicity after short course preoperative radiotherapy and total mesorectal excision for resectable rectal cancer. Clin Oncol (R Coll Radiol) 15 (2003) 233-236
15. Peeters K.C., van de Velde C.J., Leer J.W., et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients-A Dutch colorectal cancer group study. J Clin Oncol 23 (2005) 6199-6206
16. Birgisson H., Pahlman L., Gunnarsson U., et al. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 23 (2005) 8697-8705
17. Pollack J., Holm T., Cedermark B., et al. Long-term effect of preoperative radiation therapy on anorectal function. Dis Colon Rectum 49 (2006) 345-352
18. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
19. Mendenhall W.M., Bland K.I., Copeland E.M., et al. Does preoperative radiation therapy enhance the probability of local control and survival in high-risk distal rectal cancer. Ann Surg 215 (1992) 696-706
20. Myerson R.J., Michalsi J.M., King M.L., et al. Adjuvant radiation therapy for rectal carcinoma: Predictors of outcome. Int J Radiat Oncol Biol Phys 32 (1995) 41-50
21. Rich T.A., Skipper J.M., Ajani J.A., et al. Preoperative infusional chemoirradiation for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 32 (1995) 1025-1029
22. Chan R.S., Tyler D.S., Anscher M.S., et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 221 (1995) 779-787
23. Minsky B.D., Cohen A.M., Kemeny N., et al. Enhancement of radiation-induced downstaging of rectal cancer by 5-FU and high-dose leucovorin chemotherapy. J Clin Oncol 10 (1992) 79-84
24. Wagman R., Minsky B.D., Cohen A.M., et al. Sphincter prevention with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 42 (1998) 51-57
25. Hyams D.M., Mamounas E.P., Petrelli N., et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. A progress report of the National Surgical Adjuvant Breast and Bowel Project protocol R-03. Dis Colon Rectum 40 (1997) 131-139
26. Roh M.S., Colangelo L., Wieand S., et al. Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum. Proc Am Soc Clin Oncol 22 (2004) 14s (abstr 3505)
27. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
28. Bosset J.-F., Calais G., Daban A., et al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomized trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 40 (2004) 219-224
29. Bosset J.-F., Calais G., Mineur L., et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921. J Clin Oncol 23 (2005) 5620-5627
30. Bosset J.-F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
31. Gerard J.P., Bonnetain F., Conroy T., et al. Preoperative radiotherapy +/-5 FU/folinic acid in T3-4 rectal cancers: results of the FFCD 9203 randomized trial. Proc Am Soc Clin Oncol 23 (2005) 247s
32. Gerard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-T4 rectal cancer: Results of the FFCD 9203. J Clin Oncol 24 (2006) 4620-4625
33. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Long-term results of a randomized trial comparing preoperative short course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93 (2006) 1215-1223
34. Hoff P.M., Ansari R., Batist G., et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study. J Clin Oncol 19 (2001) 2282-2292
35. van Cutsem E., Twelves C., Cassidy J., et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19 (2001) 4097-4106
36. Cassidy J., Scheithauer W., McKendrick J., et al. Capecitabine versus bolus 5-FU/leucovorin as adjuvant therapy for colon cancer (the X-ACT study): efficacy results of a phase III trial. Proc Am Soc Clin Oncol 22 (2004) 14s (abstr)
37. Dunst J., Reese T., Debus J., et al. Phase II study of preoperative chemoradiation with capecitabine in rectal cancer. Proc Am Soc Clin Oncol 23 (2004) 260 (abstr)
38. DePaoli A., Chiara S., Luppi G., et al. A phase II study of capecitabine and pre-operative radiation therapy in resectable, locally advanced rectal cancer. Proc Am Soc Clin Oncol 22 (2004) 255 (abstr)
39. Dupuis O., Vie B., Lledo G., et al. Capecitabine chemoradiation in the preoperative treatment of patients with rectal adenocarcinomas: A phase II GERCOR trial. Proc Am Soc Clin Oncol 22 (2004) 255
40. Kim J.S., Cho M.J., Song K.S., et al. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 54 (2002) 403-408
41. Mitchell E.P., Anne P., Fry R., et al. Combined modality therapy of locally advanced or recurrent adenocarcinoma of the rectum: report of a phase I/II trial of chemotherapy with CPT-11, 5-FU and concomitant irradiation. Proc Am Soc Clin Oncol 20 (2001) 131a (abstr)
42. Mohiuddin M., Winter K., Mitchell E., et al. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 24 (2006) 650-655
43. Gerard J.P., Chapet O., Nemoz C., et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon R0-04 phase II trial. J Clin Oncol 21 (2003) 1119-1124
44. Ryan D.P., Niedzwiecki D., Hollis D., et al. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J Clin Oncol 24 (2006) 2557-2562
45. Willett C.G., Boucher Y., di Tomaso E., et al. Direct evidence that the VEGF specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 110 (2004) 145-147